Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who can’t get the blockbuster drug through insurance.

the Senate Health Committee grilled Novo Nordisk CEO Lars Fruergaard Jørgensen over why Wegovy and Ozempic cost hundreds of dollars less per month in countries such as France, Canada and Germany.

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly Canada to announce retaliatory tariffs on $21 billion of U.S. goods in response to Trump's steel and aluminum ...

Hikma Pharmaceuticals (HKMPF) is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents ...

Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...

Dr Reddy's plans to launch in India, Canada and Brazil as well as ... Meanwhile in the US, Novo Nordisk cut prices of Wegovy to $499 per month for cash paying patients, as it moved out of FDA ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...